131 related articles for article (PubMed ID: 19505719)
1. A chitosan hydrogel delivery system for osteosarcoma gene therapy with pigment epithelium-derived factor combined with chemotherapy.
Ta HT; Dass CR; Larson I; Choong PF; Dunstan DE
Biomaterials; 2009 Sep; 30(27):4815-23. PubMed ID: 19505719
[TBL] [Abstract][Full Text] [Related]
2. Chitosan microparticles encapsulating PEDF plasmid demonstrate efficacy in an orthotopic metastatic model of osteosarcoma.
Dass CR; Contreras KG; Dunstan DE; Choong PF
Biomaterials; 2007 Jul; 28(19):3026-33. PubMed ID: 17408737
[TBL] [Abstract][Full Text] [Related]
3. A chitosan-dipotassium orthophosphate hydrogel for the delivery of Doxorubicin in the treatment of osteosarcoma.
Ta HT; Dass CR; Larson I; Choong PF; Dunstan DE
Biomaterials; 2009 Jul; 30(21):3605-13. PubMed ID: 19345993
[TBL] [Abstract][Full Text] [Related]
4. PEDF-derived synthetic peptides exhibit antitumor activity in an orthotopic model of human osteosarcoma.
Ek ET; Dass CR; Contreras KG; Choong PF
J Orthop Res; 2007 Dec; 25(12):1671-80. PubMed ID: 17600821
[TBL] [Abstract][Full Text] [Related]
5. Pigment epithelium-derived factor overexpression inhibits orthotopic osteosarcoma growth, angiogenesis and metastasis.
Ek ET; Dass CR; Contreras KG; Choong PF
Cancer Gene Ther; 2007 Jul; 14(7):616-26. PubMed ID: 17479108
[TBL] [Abstract][Full Text] [Related]
6. Human mesenchymal stem cells overexpressing pigment epithelium-derived factor inhibit hepatocellular carcinoma in nude mice.
Gao Y; Yao A; Zhang W; Lu S; Yu Y; Deng L; Yin A; Xia Y; Sun B; Wang X
Oncogene; 2010 May; 29(19):2784-94. PubMed ID: 20190814
[TBL] [Abstract][Full Text] [Related]
7. Anti-angiogenic therapy for osteosarcoma.
Quan GM; Choong PF
Cancer Metastasis Rev; 2006 Dec; 25(4):707-13. PubMed ID: 17160710
[TBL] [Abstract][Full Text] [Related]
8. PEDF: a potential molecular therapeutic target with multiple anti-cancer activities.
Ek ET; Dass CR; Choong PF
Trends Mol Med; 2006 Oct; 12(10):497-502. PubMed ID: 16962374
[TBL] [Abstract][Full Text] [Related]
9. The performance of doxorubicin encapsulated in chitosan-dextran sulphate microparticles in an osteosarcoma model.
Tan ML; Friedhuber AM; Dunstan DE; Choong PF; Dass CR
Biomaterials; 2010 Jan; 31(3):541-51. PubMed ID: 19836833
[TBL] [Abstract][Full Text] [Related]
10. Synergistic neuroprotective effect via simian lentiviral vector-mediated simultaneous gene transfer of human pigment epithelium-derived factor and human fibroblast growth factor-2 in rodent models of retinitis pigmentosa.
Miyazaki M; Ikeda Y; Yonemitsu Y; Goto Y; Kohno R; Murakami Y; Inoue M; Ueda Y; Hasegawa M; Tobimatsu S; Sueishi K; Ishibashi T
J Gene Med; 2008 Dec; 10(12):1273-81. PubMed ID: 18837062
[TBL] [Abstract][Full Text] [Related]
11. [Effects of pigment epithelial derived factor gene on growth of lung cancer cell and neovascularization: experiments with lung cancer cells and chick embryos].
Chen JF; Zhao W; Zhang JZ; Jiang WG; Zhang LJ
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(7):485-90. PubMed ID: 19567100
[TBL] [Abstract][Full Text] [Related]
12. A chitosan hydrogel-based cancer drug delivery system exhibits synergistic antitumor effects by combining with a vaccinia viral vaccine.
Han HD; Song CK; Park YS; Noh KH; Kim JH; Hwang T; Kim TW; Shin BC
Int J Pharm; 2008 Feb; 350(1-2):27-34. PubMed ID: 17897800
[TBL] [Abstract][Full Text] [Related]
13. Co-nanoencapsulated doxorubicin and Dz13 control osteosarcoma progression in a murine model.
Tan ML; Friedhuber AM; Dass CR
J Pharm Pharmacol; 2013 Jan; 65(1):35-43. PubMed ID: 23215686
[TBL] [Abstract][Full Text] [Related]
14. [Gene therapy for retinal disease].
Kohno R; Yonemitsu Y; Ikeda Y
Nihon Rinsho; 2005 Dec; 63 Suppl 12():679-87. PubMed ID: 16416873
[No Abstract] [Full Text] [Related]
15. Systemically administered PEDF against primary and secondary tumours in a clinically relevant osteosarcoma model.
Broadhead ML; Dass CR; Choong PF
Br J Cancer; 2011 Nov; 105(10):1503-11. PubMed ID: 21979423
[TBL] [Abstract][Full Text] [Related]
16. A novel controlled local drug delivery system for inner ear disease.
Paulson DP; Abuzeid W; Jiang H; Oe T; O'Malley BW; Li D
Laryngoscope; 2008 Apr; 118(4):706-11. PubMed ID: 18182968
[TBL] [Abstract][Full Text] [Related]
17. Acute toxicity study of a simian immunodeficiency virus-based lentiviral vector for retinal gene transfer in nonhuman primates.
Ikeda Y; Yonemitsu Y; Miyazaki M; Kohno R; Murakami Y; Murata T; Goto Y; Tabata T; Ueda Y; Ono F; Suzuki T; Ageyama N; Terao K; Hasegawa M; Sueishi K; Ishibashi T
Hum Gene Ther; 2009 Sep; 20(9):943-54. PubMed ID: 19416079
[TBL] [Abstract][Full Text] [Related]
18. [In vitro experimental study of adriamycin-loaded chitosan drug delivery system].
Zhang Y; Hou C; Chen A
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 1997 Sep; 11(5):309-11. PubMed ID: 9867937
[TBL] [Abstract][Full Text] [Related]
19. Synergistic anti-tumor activity of paclitaxel-incorporated conjugated linoleic acid-coupled poloxamer thermosensitive hydrogel in vitro and in vivo.
Guo DD; Xu CX; Quan JS; Song CK; Jin H; Kim DD; Choi YJ; Cho MH; Cho CS
Biomaterials; 2009 Sep; 30(27):4777-85. PubMed ID: 19524293
[TBL] [Abstract][Full Text] [Related]
20. Injectable chitosan-based hydrogel for implantable drug delivery: body response and induced variations of structure and composition.
Sun J; Jiang G; Qiu T; Wang Y; Zhang K; Ding F
J Biomed Mater Res A; 2010 Dec; 95(4):1019-27. PubMed ID: 20872751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
